(1)
Hide, M.; Park, H.-S.; Igarashi, A.; Ye, Y.-M.; Kim, T.-B.; Yagami, A. Efficacy and Safety of Omalizumab in Japanese and Korean Patients With Chronic Idopathic/Spontaneous Urticaria (CIU/CSU: Results from the Phase 3 POLARIS Study. J of Skin 2017, 1, s126.